Healthcare >> CEO Interviews >> April 12, 1999

David W. Barry – Triangle Pharmaceuticals Inc (virs)

DAVID W. BARRY, M.D. founded Triangle Pharmaceuticals, Inc. in 1995 and is Chairman and CEO. Dr. Barry received his undergraduate education at the Sorbonne and Yale University where he graduated magna cum laude in 1965. While earning his M.D. degree at Yale, he began his career in Virology in 1967 as a Research Associate at the Rockefeller Foundation- Yale Arborvirus Research Unit. Following internship and residency training at Yale New Haven Hospital, Dr. Barry joined the Food and Drug Administration in 1972, where he was director of the General Virology Branch and later acting deputy director of the Division of Virology as well as director of the Influenza Task Force. Dr. Barry joined Burroughs Wellcome in 1977 as head of the Department of Virology and director of clinical investigation. Dr. Barry was named vice president of research, development & medical affairs (RD&M) at Burroughs Wellcome in September of 1989 and group director of RD&M in 1994. He was also a member of the Board of Directors of the Burroughs Wellcome Co., the Wellcome Foundation and Family Health International. He is currently Chairman of the Inter-Company Collaboration of AIDS Drug Development. Dr. Barry is a Board Certified Specialist in Internal Medicine and Infectious Diseases, and an Adjunct Professor of Medicine at Duke University. He has written nearly 100 scientific articles and is a co-inventor of the use of AZT to treat HIV infections. Profile
TWST: First, give us a background summary on Triangle, enough

information to put it into context concerning what you see as your

business and what you see as your company today?

Dr. Barry: